<DOC>
	<DOCNO>NCT00672607</DOCNO>
	<brief_summary>To compare efficacy safety Agnucaston tablets placebo treatment Premenstrual Syndrome ( PMS ) ass Agnucaston tablet superior placebo efficacy .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety Agnucaston Tablets Treatment Premenstrual Syndrome ( PMS )</brief_title>
	<detailed_description>Premenstrual syndrome ( PMS ) common disorder woman consist somatic and/or behavioral/mood symptom , impair woman 's social work-related functioning . Some clinical study preparation contain Vitex agnus castus demonstrate positive effect PMS good tolerability . The aim clinical trial investigate efficacy safety Agnucaston tablets therapy PMS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Premenstrual Syndrome</mesh_term>
	<criteria>clinical diagnosis PMS disease Age 18 45 year Patients general good health Any follow endocrinological disease : diabetes mellitus , hypo/hyperthyreosis , pituitary tumor . Clearly kidney liver disease , abnormal kidney liver function . Any following gynecological disease : endometriosis , mammary carcinoma , intraductal papilloma , galactorrhea , mammary fibroadenoma . Prior start study plan surgical intervention breast ( include cyst puncture ) , uterus and/ adnexa .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>premenstual syndrome , PMS , clinical trial</keyword>
</DOC>